The University of Chicago Header Logo

Connection

Hedy Kindler to NF-kappa B

Back to Details
This is a "connection" page, showing publications Hedy Kindler has written about NF-kappa B.
Hedy Kindler
Connection Strength
0.018
NF-kappa B
  1. A multicenter, phase II study of bortezomib (PS-341) in patients with unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma. Invest New Drugs. 2011 Dec; 29(6):1475-81.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.